Marc Brisson was awarded a CIHR Canadian Immunization Research Network (CIRN) Grant: “Optimization of HPV vaccination and screening in Canada, considering opportunities provided by 1-dose vaccination: A mathematical modeling study”.

Our team presented at the International Papillomavirus Conference 2023 held in Washington DC, April 17-22, 2023:

• Jean-François Laprise made an oral presentation on the “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in high-income countries: A mathematical modeling study using North America as an example”.
• Élodie Bénard made a poster presentation on the “Potential impact of one-dose HPV vaccination in low-and middle-income countries: a modelling analysis”.

Our proposal received an overall rating (out of 5) of 4.7 in the Digital Research Alliance of Canada 2023 resource allocation competition (Fast track application). Our research group was awarded 399 core-years on Calcul Québec’s Narval supercomputer, which is estimated to an annual contribution of $42,000 from the Alliance.

• Marc Brisson was invited speaker for 2 presentations: the first on “Modelling the impact of HPV vaccination on colposcopy results in highly vaccinated populations” and the second on “Modelling the impact of 1-dose HPV vaccination”.
• Mélanie Drolet presented on the “Potential impact of one-dose HPV vaccination in low-and-middle-income countries (LMIC): A modeling analysis using HPV-ADVISE LMIC”.

Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020)